aap Reports EUR 5.8 Million Sales Revenue and EUR 0.2 Million EBITDA in Q1 2010
(Thomson Reuters ONE) -
aap Implantate AG / aap Reports EUR 5.8 Million Sales Revenue and EUR 0.2 Million EBITDA in Q1 2010 processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
aap Implantate AG, a medical technology company listed in the Prime Standard
segment of the Frankfurt Stock Exchange, earned sales revenue totaling EUR 5.8
million (previous year: EUR 8.4 million) in the first three months of the
financial year 2010. Its EBITDA was EUR 0.2 million (previous year: EUR 0.8
million).
+-----------------------+---------------+---------------+--------+
| In EUR million | Q1/2010 | Q1/2009 | Change |
+-----------------------+---------------+---------------+--------+
| Sales | 5.8 | 8.4 | - 31% |
+-----------------------+---------------+---------------+--------+
| EBITDA | 0.2 | 0.8 | - 75% |
+-----------------------+---------------+---------------+--------+
| EBIT | -0.5 | 0.1 | n.a. |
+-----------------------+---------------+---------------+--------+
| EBT | -0.7 | -0.2 | n.a. |
+-----------------------+---------------+---------------+--------+
| Result after tax | -0.6 | -0.3 | n.a. |
+-----------------------+---------------+---------------+--------+
| In EUR million | Mar. 31, 2010 | Dec. 31, 2009 | Change |
+-----------------------+---------------+---------------+--------+
| Equity (equity ratio) | 44.2 (72%) | 44.7 (71%) | -1% |
+-----------------------+---------------+---------------+--------+
| Balance sheet total | 61.1 | 62.7 | -3% |
+-----------------------+---------------+---------------+--------+
| Employees | 252 | 242 | +4% |
+-----------------------+---------------+---------------+--------+
In the first quarter of 2010 the Group's EBIT amounted to EUR -0.5 million
(previous year: EUR 0.1 million). Group EBT was EUR -0.7 million (previous year:
EUR -0.2 million). On a balance sheet total of EUR 61.1 million (Dec. 31, 2009:
EUR 62.7 million) the equity ratio was 72 percent.
Disregarding project sales, the sales of the disposed Analytics business sold in
December 2009, and other one-time effects, amounting to EUR 2.4 million,
like-for-like previous year's product sales totaled EUR 5.9 million. Therefore
Q1 2010 sales were 2 percent down on the previous year.
Taking out the effects of the Analytics business and the effect of the project
business, the adjusted key performance figures for the first quarter of 2009 are
as follows:
+----------------+---------+-------------------+--------+
| In EUR million | Q1/2010 | Q1/2009 adjusted* | Change |
+----------------+---------+-------------------+--------+
| EBITDA | 0.2 | 0.2 | n.a. |
+----------------+---------+-------------------+--------+
| EBIT | -0.5 | -0.5 | n.a. |
+----------------+---------+-------------------+--------+
| EBT | -0.7 | -0.7 | n.a. |
+----------------+---------+-------------------+--------+
*Q1/2009 adjusted for effects of Analytics segment and project business
The main focus of the corporate strategy in 2010 continues to be on customers,
costs and cash. aap´s financial goal is to achieve a positive EBIT at product
level by launching new and innovative products and by launching existing
products in new markets, by expanding longstanding partnerships and by
establishing new ones in 2010. Based on current forecasts and the present state
of various negotiations the Management Board anticipates double-digit H1 sales
growth at product level.
aap Implantate AG's Q1 2010 results in full are available to download at
www.aap.de.
[HUG#1415108]
--- End of Message ---
aap Implantate AG
Lorenzweg 5 Berlin Germany
ISIN: DE0005066609;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
Unternehmensinformation / Kurzprofil:
Datum: 12.05.2010 - 08:36 Uhr
Sprache: Deutsch
News-ID 20770
Anzahl Zeichen: 0
contact information:
Town:
Berlin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 202 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"aap Reports EUR 5.8 Million Sales Revenue and EUR 0.2 Million EBITDA in Q1 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
aap Implantate AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
